SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 121 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $170,633 | +12.0% | 30,094 | +10.6% | 0.00% | – |
| Q4 2022 | $152,382 | +85.8% | 27,211 | +112.4% | 0.00% | – |
| Q3 2022 | $82,000 | +26.2% | 12,812 | -32.6% | 0.00% | – |
| Q2 2022 | $65,000 | -85.5% | 19,023 | -69.8% | 0.00% | – |
| Q1 2022 | $448,000 | -5.3% | 62,953 | +10.9% | 0.00% | – |
| Q4 2021 | $473,000 | +151.6% | 56,753 | +110.2% | 0.00% | – |
| Q3 2021 | $188,000 | -73.0% | 26,997 | -7.5% | 0.00% | -100.0% |
| Q2 2021 | $696,000 | -45.5% | 29,192 | -52.9% | 0.00% | -50.0% |
| Q1 2021 | $1,276,000 | +18.1% | 61,960 | +40.5% | 0.00% | 0.0% |
| Q4 2020 | $1,080,000 | +7100.0% | 44,097 | +2087.4% | 0.00% | – |
| Q1 2018 | $15,000 | -62.5% | 2,016 | -18.3% | 0.00% | – |
| Q3 2017 | $40,000 | – | 2,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |